Description

3-(3-Oxo-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid is a specialized heterocyclic carboxylic acid derivative that serves as a critical synthetic intermediate in advanced organic chemistry. Its unique quinoxaline-based structure makes it a valuable building block for constructing complex molecules with specific electronic and binding properties. This compound is primarily sought after by research institutions and pharmaceutical developers engaged in the synthesis of novel active pharmaceutical ingredients (APIs), agrochemicals, and functional materials.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of quinoxaline-based drug candidates, particularly those targeting neurological disorders, anti-infectives, and oncology.
• Agrochemical Research: Used in developing novel pesticides and herbicides, leveraging the bioactive quinoxaline scaffold for enhanced efficacy.
• Material Science: Serves as a monomer or functionalizing agent in the creation of advanced polymers, dyes, and organic semiconductors.
• Chemical Biology: Employed as a probe or linker molecule in bioconjugation and the study of protein-ligand interactions.
• Academic & R&D: A fundamental reagent for methodological development in organic synthesis and heterocyclic chemistry research.

Basic Information

Product Name	3-(3-Oxo-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid
CAS No.	7712-28-9
Molecular Formula	C11H10N2O3
Molecular Weight	218.21 g/mol
Synonyms	2-(2-Carboxyethyl)-3-oxo-3,4-dihydroquinoxaline; 3-(3-Oxo-3,4-dihydro-2-quinoxalinyl)propanoic Acid; Quinoxaline-2-propionic acid, 3-oxo-3,4-dihydro-; 3-(3-Oxo-3,4-dihydroquinoxalin-2-yl)propionic Acid; 2-(3-Carboxypropyl)-3-hydroxyquinoxaline; 3-Oxo-3,4-dihydro-2-quinoxalinepropanoic Acid
EINECS	Contact for details

Quality Control

Our production of 3-(3-Oxo-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid adheres to stringent in-process controls and final batch analysis to ensure consistent high purity and chemical identity. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing parameters such as assay, related substances, and residual solvents. Our quality system supports compliance with cGMP standards for pharmaceutical intermediates, and we welcome custom purity or packaging requirements for specific research or development projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Unknown Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.